{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:21Z","timestamp":1790254281798,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bone.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T04:18:11Z","timestamp":1492489091000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys"],"prefix":"10.1016","volume":"101","author":[{"given":"Rogely Waite","family":"Boyce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Tian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Ominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.04.005_bb0005","article-title":"Romosozumab improves bone mass and strength while maintaining bone quality in ovariectomized cynomolgus monkeys","author":"Ominsky","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.04.005_bb0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.04.005_bb0020","series-title":"Strength at the Lumbar Spine and Hip Improves With Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass","author":"Keaveny","year":"2015"},{"key":"10.1016\/j.bone.2017.04.005_bb0025","article-title":"Sclerostin antibody administration converts bone lining cells into active osteoblasts","author":"Kim","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0030","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/jbmr.2482","article-title":"Transcriptional profiling of laser capture microdissected subpopulations of the osteoblast lineage provides insight into the early response to sclerostin antibody in rats","volume":"30","author":"Nioi","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0035","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jbmr.2152","article-title":"Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody","volume":"29","author":"Ominsky","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0040","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1210\/en.2013-1905","article-title":"Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26weeks of treatment with a sclerostin antibody","volume":"155","author":"Li","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2017.04.005_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","article-title":"Carcinogenicity risk assessment of romosozumab: a review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study","volume":"81","author":"Chouinard","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.bone.2017.04.005_bb0050","article-title":"Effects of sclerostin antibodies in animal models of osteoporosis","author":"Ominsky","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.04.005_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0221-8747(84)90066-3","article-title":"Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition","volume":"5","author":"Eriksen","year":"1984","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0060","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/8756-3282(92)90004-G","article-title":"Reconstruction of the formative site in trabecular bone by a new, quick, and easy method","volume":"13","author":"Steiniche","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.04.005_bb0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0221-8747(84)90065-1","article-title":"Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals","volume":"5","author":"Eriksen","year":"1984","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.2188","article-title":"Bone matrix quality after sclerostin antibody treatment","volume":"29","author":"Ross","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0080","series-title":"Osteoporosis: Recent Advances in Pathogenesis and Treatment","first-page":"321","article-title":"Impaired osteoblast function in metabolic bone disease","author":"Parfitt","year":"1981"},{"key":"10.1016\/j.bone.2017.04.005_bb0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jbmr.5650110508","article-title":"Effects of intermittent hPTH(1\u201334) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone","volume":"11","author":"Boyce","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S8756-3282(00)00430-0","article-title":"Treatment with human parathyroid hormone (1\u201334) for 18months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)","volume":"28","author":"Jerome","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.04.005_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/edrv-7-4-379","article-title":"Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease","volume":"7","author":"Eriksen","year":"1986","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2017.04.005_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.5650100207","article-title":"The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site","volume":"10","author":"Boyce","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jbmr.5650080211","article-title":"Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis","volume":"8","author":"Storm","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.04.005_bb0110","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/jbmr.2830","article-title":"Finite element analysis of denosumab treatment effects on vertebral strength in ovariectomized cynomolgus monkeys","volume":"31","author":"Lee","year":"2016","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217301448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:22:48Z","timestamp":1589732568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217301448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":22,"alternative-id":["S8756328217301448"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.04.005","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Amgen Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}